AAAAAA

   
Results: 1-14 |
Results: 14
LONG-TERM SURVIVAL AND DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH ACLARUBICIN OR DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE FOLLOWED BY INTENSIVE CONSOLIDATION CHEMOTHERAPY IN A DANISH NATIONAL PHASE-III TRIAL
Authors: BROWN PD HOFFMANN T HANSEN OP BOESEN AM GRONBAEK K HIPPE E JENSEN MK THORLING K STORM HH PEDERSENBJERGAARD J
Citation: Pd. Brown et al., LONG-TERM SURVIVAL AND DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH ACLARUBICIN OR DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE FOLLOWED BY INTENSIVE CONSOLIDATION CHEMOTHERAPY IN A DANISH NATIONAL PHASE-III TRIAL, Leukemia, 11(1), 1997, pp. 37-41
IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHROMOSOME-17 ABNORMALITIES AND NOT TRISOMY-12 ARE THE SINGLE MOST IMPORTANT CYTOGENETIC ABNORMALITIES FOR THE PROGNOSIS - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480UNSELECTED NEWLY-DIAGNOSED PATIENTS
Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E BIRGENS HS DRIVSHOLM A ELLEGAARD J LARSEN JK PLESNER T BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHROMOSOME-17 ABNORMALITIES AND NOT TRISOMY-12 ARE THE SINGLE MOST IMPORTANT CYTOGENETIC ABNORMALITIES FOR THE PROGNOSIS - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480UNSELECTED NEWLY-DIAGNOSED PATIENTS, Leukemia research, 21(11-12), 1997, pp. 1011-1023
IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE
Authors: GEISLER CH HANSEN MM PHILIP P CHRISTENSEN BE HOUJENSEN K TINGGAARDPEDERSEN N JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H NIELSEN JB ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK
Citation: Ch. Geisler et al., IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE, Blood, 90(10), 1997, pp. 2358-2358
OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT
Authors: JOHNSEN HE BJORKSTRAND B CARLSON K GRUBER A BLYSTAD A FAST A BOESEN AM BJORKHOLM M SALLERFORS B RUUTU T CARNESKOG J MALM A GEISLER C LEHTINEN M SCHRODER H BRINCH L REMES K TIDEFELT U HEILMANN C HORNSTEN P THORLING K DAUGAARD G
Citation: He. Johnsen et al., OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT, Leukemia & lymphoma, 24(1-2), 1996, pp. 81-91
THE BONE-MARROW INFILTRATION PATTERN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS NOT AN IMPORTANT PROGNOSTIC FACTOR
Authors: GEISLER CH HOUJENSEN K JENSEN OM TINGGARDPEDERSEN N HANSEN MM HANSEN NE HOLM M CHRISTENSEN BE DRIVSHOLM A NIELSEN JB THORLING K ANDERSEN E
Citation: Ch. Geisler et al., THE BONE-MARROW INFILTRATION PATTERN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IS NOT AN IMPORTANT PROGNOSTIC FACTOR, European journal of haematology, 57(4), 1996, pp. 292-300
RISK-FACTORS FOR CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS-LYMPHOMA - A MULTIVARIATE-ANALYSIS
Authors: KELDSEN N MICHALSKI W BENTZEN SM HANSEN KB THORLING K
Citation: N. Keldsen et al., RISK-FACTORS FOR CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS-LYMPHOMA - A MULTIVARIATE-ANALYSIS, Acta oncologica, 35(6), 1996, pp. 703-708
TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS
Authors: GEISLER CH PHILIP P CHRISTENSEN BE HOUJENSEN K PEDERSEN NT JENSEN OM THORLING K ANDERSEN E HANSEN NE NIELSEN H ELLEGAARD J LARSEN JK BROWN P ANDERSEN PK HANSEN MM
Citation: Ch. Geisler et al., TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS, Blood, 88(10), 1996, pp. 937-937
CLINICOPATHOLOGICAL FEATURES, SURVIVAL AND PROGNOSTIC FACTORS OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - TRENDS IN INCIDENCE OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS AND PRIMARY MALIGNANT BRAIN-TUMORS INA WELL-DEFINED GEOGRAPHICAL AREA - POPULATION-BASED DATA FROM THE DANISH LYMPHOMA REGISTRY, LYFO, AND THE DANISH CANCER REGISTRY
Authors: KROGHJENSEN M DAMORE F JENSEN MK CHRISTENSEN BE THORLING K PEDERSEN M JOHANSEN P BOESEN AM ANDERSEN E
Citation: M. Kroghjensen et al., CLINICOPATHOLOGICAL FEATURES, SURVIVAL AND PROGNOSTIC FACTORS OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - TRENDS IN INCIDENCE OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS AND PRIMARY MALIGNANT BRAIN-TUMORS INA WELL-DEFINED GEOGRAPHICAL AREA - POPULATION-BASED DATA FROM THE DANISH LYMPHOMA REGISTRY, LYFO, AND THE DANISH CANCER REGISTRY, Leukemia & lymphoma, 19(3-4), 1995, pp. 223-233
CNS INVOLVEMENT IN NON-HODGKINS-LYMPHOMA (NHL)
Authors: KELDSEN N MICHALSKI W BENTZEN SM THORLING K
Citation: N. Keldsen et al., CNS INVOLVEMENT IN NON-HODGKINS-LYMPHOMA (NHL), European journal of cancer, 31A, 1995, pp. 791-791
INCIDENCE, CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY
Authors: KROGHJENSEN M DAMORE F JENSEN MK CHRISTENSEN BE THORLING K PEDERSEN M JOHANSEN P BOESEN AM ANDERSEN E
Citation: M. Kroghjensen et al., INCIDENCE, CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY, Annals of oncology, 5(4), 1994, pp. 349-354
NON-HODGKINS-LYMPHOMA OF THE GASTROINTESTINAL-TRACT - A POPULATION-BASED ANALYSIS OF INCIDENCE, GEOGRAPHIC-DISTRIBUTION, CLINICOPATHOLOGICAL PRESENTATION FEATURES, AND PROGNOSIS
Authors: DAMORE F BRINCKER H GRONBAEK K THORLING K PEDERSEN M JENSEN MK ANDERSEN E PEDERSEN NT MORTENSEN LS
Citation: F. Damore et al., NON-HODGKINS-LYMPHOMA OF THE GASTROINTESTINAL-TRACT - A POPULATION-BASED ANALYSIS OF INCIDENCE, GEOGRAPHIC-DISTRIBUTION, CLINICOPATHOLOGICAL PRESENTATION FEATURES, AND PROGNOSIS, Journal of clinical oncology, 12(8), 1994, pp. 1673-1684
THE BONE-MARROW INFILTRATION PATTERN IN CD5-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA HAS NO INDEPENDENT PROGNOSTIC-SIGNIFICANCE( B)
Authors: GEISLER CH HOUJENSEN K JENSEN OM TINGGAARDPEDERSEN N HANSEN MM HANSEN NE HOLM M CHRISTENSEN BE DRIVSHOLM A NIELSEN JB THORLING K ANDERSEN E LARSEN JK ANDERSEN PK
Citation: Ch. Geisler et al., THE BONE-MARROW INFILTRATION PATTERN IN CD5-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA HAS NO INDEPENDENT PROGNOSTIC-SIGNIFICANCE( B), Blood, 84(10), 1994, pp. 10000525-10000525
INCIDENCE, PRESENTING FEATURES AND PROGNOSIS OF LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY
Authors: DAMORE F CHRISTENSEN BE THORLING K PEDERSEN M JENSEN MK BOESEN AM ANDERSEN E JOHANSEN P MORTENSEN LS
Citation: F. Damore et al., INCIDENCE, PRESENTING FEATURES AND PROGNOSIS OF LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY, Leukemia & lymphoma, 12(1-2), 1993, pp. 69-77
MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY
Authors: KELDSEN N BJERRUM OW DAHL IMS DRIVSHOLM A ELLEGAARD J GADEBERG O GIMSING P GRONVOLD T HANSEN MM HIPPE E LAMVIK J LY B SKARBOVIK A TALSTAD I THORLING K WESENBERG K WISLOFF F
Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85
Risultati: 1-14 |